[Synthesis and antitumor activity of S-hexyl(heptyl) substituted ethanethioate derivatives].

To simplify the macrocyclic fragment and to modify the zinc binding group of the natural product apicidin, two series of S-hexyl (heptyl) ethanethioate derivatives were designed and synthesized. Twenty-six compounds were synthesized and confirmed with 1H NMR, IR, MS and HR-MS spectrum, which were not reported. Take vorinostat as control, their antiporliferative activities against cancer cell lines, MCF-7 and HL-60, were tested with MTT assay or trypan blue staining method. Generally in both series it was found that, the chiral carbon atom at 7 position is not necessary, compounds II-1, II-3, II-6 and II-13 showed good activity on HL-60 cells in vitro, with the IC50 values less than 10 micromol x L(-1). II-7 and II-8 showed stronger activity against MCF-7 than Vorinostat, with the IC50 of 3.19 and 6.29 micromol x L(-1), respectively.

[Patients' experiences with the Forsus appliance].

PURPOSE: To investigate patients' experiences with the Forsus appliance. METHODS: This questionnaire survey was focused on patients' comprehensive experiences with Forsus, both initially and after several months of wearing, including the patients' overall impressions of the appliance. The survey was conducted in 64 patients wearing Forsus. RESULTS: A high percentage of patients(83.7%) reported neutral to favorable experience with Forsus. 85.4% of patients reported gradual adaption to the appliance within 4 weeks. Cheek irritation was the most serious side effect (about 52%). Cheek irritation and other side effect disappeared over time. CONCLUSIONS: The Forsus appliance is relatively well accepted by patients. Most patients experience some discomfort and functional limitations at first. However, the side effect gradually diminishes with time, and the patients adapt to the appliance finally. Practitioners should be especially vigilant about problems of cheek irritation.